Table 3.
Type of sample positivity | No. of positive urine HPV test samples / no. of positive cervical samples (%) by signal strength of LA-HPV | No. of positive urine HPV test samples / no. of positive cervical samples (%) by signal strength o f LA-HPV | ||||
---|---|---|---|---|---|---|
| ||||||
Strong signal | ≤Moderate signal | P value | ≥Moderate signal | ≤Weak signal | P value | |
|
|
|||||
Trovagene urine HPV test positive | 45/48 (93.8) | 6/7(85.7) | 0.43 | 48/51 (94.1) | 3/4 (75.0) | 0.27 |
Urine LA-HPV test positive | 41/48 (85.4) | 4/7 (57.1) | 0.09 | 43/51 (84.3) | 2/4 (50.0) | 0.01 |
Footnote: Hybridization signal strengths of the cervical samples presented in the Table is noted on a semi-quantitative scale as strong, moderate, weak, very weak and extremely weak signals. “≥Moderate signal” refers to strong or moderate signals, “≤moderate signal” refers to moderate, weak, very weak, or extremely weak signals, “≤weak signal” refers to weak, very weak, or extremely weak signals. The p-values for comparing differences in proportions of urine HPV positivity by corresponding categories of cervical signal strength positivity were computed by the Fisher's exact test.